Search Results - Xiongwei Xu

The correlation between the costs and clinical benefits of PD-1/PD-L1 inhibitors in malignant tumors: An evaluation based on ASCO and ESMO frameworks by Shen Lin, Shen Lin, Yaping Huang, Yaping Huang, Liangliang Dong, Meiyue Li, Yahong Wang, Dian Gu, Wei Wu, Wei Wu, Dongni Nian, Dongni Nian, Shaohong Luo, Shaohong Luo, Xiaoting Huang, Xiaoting Huang, Xiongwei Xu, Xiongwei Xu, Xiuhua Weng, Xiuhua Weng

Connect to this object online.